ES2111617T3 - Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii. - Google Patents

Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii.

Info

Publication number
ES2111617T3
ES2111617T3 ES92309333T ES92309333T ES2111617T3 ES 2111617 T3 ES2111617 T3 ES 2111617T3 ES 92309333 T ES92309333 T ES 92309333T ES 92309333 T ES92309333 T ES 92309333T ES 2111617 T3 ES2111617 T3 ES 2111617T3
Authority
ES
Spain
Prior art keywords
angiotensin
antagonists
condensed
pirimidine derivatives
pirimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92309333T
Other languages
English (en)
Spanish (es)
Inventor
John Watson Ellingboe
Madelene Nikaido
Jehan Franroz Bagli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/782,025 external-priority patent/US5149699A/en
Priority claimed from GB9207560A external-priority patent/GB2265899A/en
Priority claimed from US07/901,485 external-priority patent/US5256654A/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2111617T3 publication Critical patent/ES2111617T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES92309333T 1991-10-24 1992-10-14 Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii. Expired - Lifetime ES2111617T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/782,025 US5149699A (en) 1991-10-24 1991-10-24 Substituted pyridopyrimidines useful as antgiotensin II antagonists
GB9207560A GB2265899A (en) 1992-04-07 1992-04-07 Substituted pyrimidines
US07/901,485 US5256654A (en) 1991-10-24 1992-06-25 Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists

Publications (1)

Publication Number Publication Date
ES2111617T3 true ES2111617T3 (es) 1998-03-16

Family

ID=27266132

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92309333T Expired - Lifetime ES2111617T3 (es) 1991-10-24 1992-10-14 Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii.

Country Status (20)

Country Link
EP (1) EP0539086B1 (h)
JP (1) JP3240192B2 (h)
KR (1) KR100286624B1 (h)
CN (2) CN1039324C (h)
AT (1) ATE161537T1 (h)
AU (1) AU653635B2 (h)
CA (1) CA2080705C (h)
DE (1) DE69223734T2 (h)
DK (1) DK0539086T3 (h)
ES (1) ES2111617T3 (h)
FI (1) FI103971B1 (h)
GR (1) GR3025926T3 (h)
HU (2) HU218786B (h)
IL (1) IL103436A (h)
LV (1) LV12047B (h)
NO (1) NO301275B1 (h)
SG (1) SG47626A1 (h)
SK (1) SK280292B6 (h)
TW (1) TW226375B (h)
UA (1) UA27748C2 (h)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010106A1 (en) * 1991-11-18 1993-05-27 E.I. Du Pont De Nemours And Company Tetrazolylphenylboronic acid intermediates for the synthesis of aii receptor antagonists
EP0618207B1 (en) * 1993-03-24 1999-01-07 American Home Products Corporation Substituted pyridopyrimidines as antihypertensives
EP0782996B1 (en) * 1994-09-20 1999-02-17 Wakunaga Seiyaku Kabushiki Kaisha Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AR033390A1 (es) 2000-08-22 2003-12-17 Novartis Ag Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
GB0402262D0 (en) 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
TW200605867A (en) 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
KR20130048281A (ko) 2004-10-08 2013-05-09 노파르티스 아게 확장기 기능장애 또는 확장기 심부전의 예방 또는 치료를 위한 레닌 억제제의 용도
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
MX2009012917A (es) * 2007-06-07 2010-01-14 Sigma Tau Ind Farmaceuti Derivados de 5beta, 14-beta-androestano utiles para el tratamiento de restenosis despues de angioplastia o endoarterectomia y enfermedades debido a la fibrosis de organos.
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2475428B1 (en) 2009-09-11 2015-07-01 Probiodrug AG Heterocylcic derivatives as inhibitors of glutaminyl cyclase
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
US20130158080A1 (en) 2011-12-15 2013-06-20 Takeda Pharmaceuticals U.S.A., Inc. Methods for treating hypertension in black patients
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
JPH05504969A (ja) * 1990-02-13 1993-07-29 メルク・エンド・カムパニー・インコーポレーテツド 置換ベンジル要素を含有するアンギオテンシン２アンタゴニスト類
IL100917A0 (en) 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
HK1003031A1 (en) 1998-09-30
FI924397L (fi) 1993-04-25
NO924121D0 (no) 1992-10-23
KR100286624B1 (ko) 2001-05-02
FI103971B (fi) 1999-10-29
FI924397A0 (fi) 1992-09-30
SK322192A3 (en) 1999-11-08
HUT62893A (en) 1993-06-28
SK280292B6 (sk) 1999-11-08
UA27748C2 (uk) 2000-10-16
LV12047A (lv) 1998-05-20
EP0539086B1 (en) 1997-12-29
HU9203161D0 (en) 1992-12-28
EP0539086A3 (en) 1993-06-16
CN1175414A (zh) 1998-03-11
LV12047B (en) 1998-08-20
FI103971B1 (fi) 1999-10-29
IL103436A0 (en) 1993-03-15
JPH05222039A (ja) 1993-08-31
NO924121L (no) 1993-04-26
DK0539086T3 (da) 1998-02-02
EP0539086A2 (en) 1993-04-28
CA2080705A1 (en) 1993-04-25
IL103436A (en) 1996-03-31
CA2080705C (en) 2002-12-03
ATE161537T1 (de) 1998-01-15
JP3240192B2 (ja) 2001-12-17
AU653635B2 (en) 1994-10-06
TW226375B (h) 1994-07-11
DE69223734T2 (de) 1998-04-16
AU2607992A (en) 1993-04-29
KR930007949A (ko) 1993-05-20
DE69223734D1 (de) 1998-02-05
GR3025926T3 (en) 1998-04-30
SG47626A1 (en) 1998-04-17
HU211915A9 (en) 1996-01-29
NO301275B1 (no) 1997-10-06
CN1072682A (zh) 1993-06-02
CN1039324C (zh) 1998-07-29
HU218786B (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
ES2111617T3 (es) Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii.
PT1005453E (pt) Compostos de benzeno substituido como agentes de reducao antiproliferativa
CY1107475T1 (el) Αναστολεις ρο-κινασης
ES2114882T3 (es) Acidos hidroxialquilquinolinos insaturados como antagonistas de leucotrienos.
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
BR9810366A (pt) Derivados de ácido 4-bromo ou 4-iodo fenilamino benzidroxîmico e seu uso como inibidores de mek
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE556713T1 (de) Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
ES2172585T3 (es) Derivado de benzoimidazol.
BR0002518A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
ES2052463T1 (es) Antihipercolesterolemicos.
CO5611124A2 (es) Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
MX9606494A (es) Compuestos organicos.
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
MX9307047A (es) Compuestos de quinazolinas y bencimidazoles substituidos.
UY26498A1 (es) Pirroles sustituidos
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
BR0002514A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
DK0522001T3 (da) Understøttende anvendelse af Linomide
ES2159087T3 (es) Oxindoles sustituidos con adamantilo como agentes farmaceuticos.
ECSP972204A (es) Pirroles sustituidos
ATE360432T1 (de) Peptid zur behandlung von nervenerkrankungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539086

Country of ref document: ES